Search clinical trials for: Curosurf®

Total 13723 results

Chiesi Farmaceutici S.p.A.

Terminated

Poractant Alfa (Curosurf®)) -- Effect in Adult Patients Diagnosed With 2019 Novel Coronavirus (SARS-COV-19; (Covid-19)) Acute Respiratory Distress Syndrome (ARDS)

Acute Respiratory Distress Syndrome

United States, Italy, United Kingdom
University of Michigan
Cornerstone Pharmaceuticals

Withdrawn

Comparison in Pulmonary Compliance Between Curosurf and Survanta in Preterm Infants With Respiratory Distress Syndrome

Respiratory Distress Syndrome

United States
Chiesi Farmaceutici S.p.A.

Completed

Efficacy of Combining Prophylactic Curosurf With Early Nasal CPAP in Delivery Room: the Curpap Study (Curpap)

Respiratory Distress Syndrome, Newborn

Italy, Spain, Czechia, France, Portugal
Windtree Therapeutics

Terminated

Trial To Assess The Safety And Tolerability Of Lucinactant For Inhalation In Preterm Neonates 26 to 28 Weeks PMA

Respiratory Distress Syndrome

Canada, United States, Chile, Poland
Alan Fujii
Dey LP

Terminated

Curosurf and Survanta Treatment(CAST)of RDS in Very Premature Infants (CAST)

Respiratory Distress Syndrome | Patent Ductus Arteriosus | Prematurity

United States
Chiesi Farmaceutici S.p.A.

Terminated

A Study To InvestigateThe Safety, Tolerability And Efficacy Of Nebulised Curosurf® In Preterm Neonates With Respiratory Distress Syndrome (RDS)

Neonatal Respiratory Distress Syndrome

Italy
Chiesi Farmaceutici S.p.A.

Terminated

A Study in Preterm Neonates With Respiratory Distress Syndrome (RDS) Comparing CUROSURF® Administration Through Less Invasive Surfactant Administration (LISA) and Conventional Administration (LISPAP)

Respiratory Distress Syndrome (RDS)

United States
Hospital Clinic of Barcelona

Not yet recruiting

Intratracheal Budesonide With Surfactant to Prevent Bronchopulmmonary Dysplasia. (BuS)

Bronchopulmonary Dysplasia | Prematurity | Respiratory Distress Syndrome in Premature Infant
Dr. Sami Ulus Children's Hospital

Completed

Comparison of Two Different Natural Surfactants in the Treatment of Pulmonary Hemorrhage

Pulmonary Hemorrhage

Turkey
Ottawa Hospital Research Institute

Completed

A Multi-center Trial to Determine if Curosurf® Reduces the Duration of Mechanical Ventilation in Very Preterm Infants

Respiratory Distress Syndrome

Canada
Jean Michel Hascoet
Chiesi Farmaceutici S.p.A.; ARAIRLOR

Completed

Exogenous Surfactant in Very Preterm Neonates in Prevention of Bronchopulmonary Dysplasia (CURDYS)

Infant, Premature, Diseases | Respiratory Distress Syndrome, Newborn | Bronchopulmonary Dysplasia

France
University of Cologne
Charite University, Berlin, Germany; German Federal Ministry of Education and... and other collaborators

Completed

Surfactant Application During Spontaneous Breathing With Continuous Positive Airway Pressure (CPAP) in Premature Infants < 27 Weeks (NINSAPP)

Respiratory Distress Syndrome, Newborn

Germany
University of Sao Paulo
Ministry of Health, Brazil

Completed

A Multicenter, Randomized, Open Label Trial of a New Animal Extracted Surfactant to Treat RDS in Preterm Infants

Respiratory Distress Syndrome

Brazil
University of Michigan
Chiesi Farmaceutici S.p.A.

Terminated

Cold Heart Study: A Randomized Pilot Trial of Surfactant Therapy

Congenital Heart Disease | Hypoplastic Left Heart Syndrome

United States
University of Missouri-Columbia

Completed

Comparison of Curosurf and Infasurf in the Treatment of Preterm Infants With Respiratory Distress Syndrome (NEOSURF)

Respiratory Distress Syndrome

United States
Windtree Therapeutics
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Trial to Assess the Safety and Tolerability of Lucinactant for Inhalation in Premature Neonates

Respiratory Distress Syndrome

United States
Dr. Sami Ulus Children's Hospital

Completed

Perfusion Index Variability in Respiratory Distress Syndrome

Poor Peripheral Perfusion
Windtree Therapeutics

Completed

The Safety and Efficacy of Lucinactant for Inhalation in Premature Neonates 26 to 32 Weeks Gestational Age

Respiratory Distress Syndrome

United States, Canada, Colombia, Hungary, Chile, Ireland, Netherlands, Poland
Windtree Therapeutics

Terminated

A Safety and Efficacy Study of Lucinactant for Inhalation in Preterm Neonates 26 to 32 Weeks Gestational Age

Respiratory Distress Syndrome, Newborn

Poland
Daping Hospital and the Research Institute of Surgery...

Unknown

Efficacy of Surfactant and Perinatal Risk Factors in NRDS With Different Gestational Ages

Infant, Newborn, NRDS

China
Azienda Ospedaliera Universitaria Integrata Verona

Terminated

Efficacy and Safety of Curosurf® in Patients Invasively Ventilated for Severe Bronchiolitis Under 12 Months of Age

Bronchiolitis, Viral

Italy
NICHD Neonatal Research Network
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Recruiting

The Budesonide in Babies (BiB) Trial (BiB)

Respiratory Distress Syndrome | Bronchopulmonary Dysplasia (BPD) | Prematurity; Extreme | Neonatal

United States
VENTO GIOVANNI

Recruiting

Late Surfactant After a Recruitment Maneuver in Extremely Low Gestational Age Newborns - LATE-REC-SURF Trial (LateRecSurf)

Bronchopulmonary Dysplasia | Chronic Pulmonary Insufficiency of Prematurity

Italy
Catholic University of the Sacred Heart
Monash University; Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico; Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) and other collaborators

Completed

Efficacy of a New Technique -"IN-REC-SUR-E"- in Preterm Neonates With RDS

Respiratory Distress Syndrome | Hyaline Membrane Disease

Italy
HaEmek Medical Center, Israel
Carmel Medical Center

Unknown

Surfactant Administration Via Thin Catheter Using a Specially Adapted Video Laryngoscope (VISUAL)

Respiratory Distress Syndrome

Israel
nihat demir

Unknown

Does The Surfactant Administration by Aerosolization Effective?

Respiratory Distress Syndrome | Surfactant Administration by Aerosolization
Hospital Central "Dr. Ignacio Morones Prieto"
Universidad Autonoma de San Luis Potosí

Unknown

Efficacy of Adding Budesonide to Poractant Alfa to Prevent Bronchopulmonary Dysplasia.

Respiratory Distress Syndrome | Bronchopulmonary Dysplasia | Infant,Premature

Mexico
University of North Carolina, Chapel Hill
Windtree Therapeutics; Cystic Fibrosis Foundation

Completed

Effect of Lucinactant on Mucus Clearance in Cystic Fibrosis Lung Disease

Cystic Fibrosis

United States
Dong-A ST Co., Ltd.

Completed

A Study to Demonstrate the Efficacy and Safety of Motilitone®

Functional Dyspepsia

Korea, Republic of
Galderma R&D

Completed

Cetaphil Restoraderm Effect on Young Children With Atopic Dermatitis

Atopic Dermatitis

Philippines, China
Chong Kun Dang Pharmaceutical

Completed

CKD-391 DDI : Atorvastatin and Ezetimibe in Healthy Volunteers

Healthy

Korea, Republic of
Amir Azarpazhooh
Institut Straumann AG

Completed

Effect of Emdogain® on Soft Tissue Wound Healing

Periodontal Inflammation | Crown Lengthening

Canada
Novartis Pharmaceuticals

Completed

Inspiratory Flow Rates Achieved by the COPD Patients Through Breezhaler®, Ellipta® and Handihaler® Inhaler Devices

Pulmonary Disease, Chronic Obstructive (COPD)

Argentina
Guerbet

Completed

Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/Gadavist®-Enhanced MRI in the Diagnosis of Brain Tumors (REMIND)

Primary Brain Tumor

Colombia, Korea, Republic of, United States, Mexico
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immune Response of Different Pediatric Combination Vaccines.

Pertussis | Diphtheria | Polio

United States
Chung-Ang University Hosptial, Chung-Ang University...

Unknown

A Study to Evaluate the Efficacy Between Helicobacter Pylori Eradication Therapy and Motilitone in Functional Dyspepsia

Functional Dyspepsia

Korea, Republic of
University of Miami
BSN Medical Inc

Recruiting

VLU Dressing Study

Venous Leg Ulcer

United States
Sanofi Pasteur, a Sanofi Company

Completed

Rates of Pertussis Disease Among Persons Receiving Pentacel® or Other Pertussis Vaccines

Pertussis

United States
Coopervision, Inc.

Completed

Clinical Evaluation of Biofinity Multifocal Compared With Air Optix Aqua Multifocal and With PureVision Multifocal (INNOVATION)

Presbyopia
Tufts University

Completed

Comparison of Post Tooth Extraction Healing Using Different Xenograft Materials

Alveolar Bone Loss

United States
Assistance Publique Hopitaux De Marseille

Completed

Clinical Evaluation of the Treatment of Intellectual Metastases by Radiosurgery Gamma Knife by Means of a Support System by Mask. (Mask)

Lung Cancer | Brain Metastases

France
Global Kinetics Corporation

Withdrawn

Utilization of Target Ranges to Treat Persons With Parkinson's Disease by Objective Measurement Using the PKG (TARGET-PwP)

Parkinson Disease
University Hospital, Caen

Completed

Incidence of Dual Mobility Polyethylene Wear in Total Hip Prosthesis. Randomised Study Versus Fixed Insert by Radiostereometric Analysis. (DOUMOB)

Total Hip Replacement
Chiesi Farmaceutici S.p.A.

Completed

Pharmacokinetic Study of Bramitob® Administered for Inhalation by PARI eFlow® vs PARI LC® PLUS Nebulizer

Cystic Fibrosis

Czechia, Moldova, Republic of, Slovakia
Hoffmann-La Roche

Completed

A Study to Assess All-Cause Mortality and Cardiovascular Morbidity in Participants With Chronic Kidney Disease (CKD) on Dialysis and Those Not on Renal Replacement Therapy Receiving Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) or Reference Erythropoietin Stimulating Agents (ESAs)

Chronic Renal Anemia

Belgium, Brazil, United Kingdom, Serbia, Spain, Germany, Korea, Republic of, Turkey, Lithuania, Italy, Czechia, Argentina, Australia, Croatia, France, Greece, Israel, Malaysia, Mexico, Panama, Philippines, Poland, Russian Federation, ... and more
Global Kinetics Corporation

Terminated

Utilization of Target Ranges to Treat Parkinson's Disease With the PKG (TARGET-PD)

Parkinson Disease

United States
nthalmic Pty Ltd
Brighten Optix Corporation

Recruiting

S.T.O.P.® Technology Contact Lenses Versus Dual-focus Contact Lenses for Slowing Down Myopia Progression in Children

Myopia

India, Spain, China
Lument AB

Terminated

A Randomized, Controlled Trial to Evaluate CT Image Quality Lumentin® 44

Subjects Referred to CT-examination of the Abdomen

Sweden
W.L.Gore & Associates

Completed

GORE® TAG® Thoracic Endoprosthesis French Mandatory Registry

Aortic Diseases | Aortic Aneurysm, Thoracic | Penetrating Ulcer | Descending Thoracic Aortic Dissection | Aorta Thoracic; Traumatic Rupture

France
Revance Therapeutics, Inc.

Active, not recruiting

Teosyal RHA® Histology and Intradermal Implantation Evaluation Study

Histology

Canada

Search clinical trials for: Curosurf®

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Qatar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations